Commercialising research by creating newco’s with OSE
No virtual option for this seminar.
Are you interested in Translational funding and potentially commercialising your research?

Oxford Science Enterprises (OSE) was founded in 2015 to help bring Oxford’s best ideas to the world by creating transformational businesses via a unique partnership with the University of Oxford. Together with the University OSE has worked with Academic Founders to create a phenomenal science-business ecosystem whereby investment in university spinouts has increased to £1.4bn in 2021, attracting an impressive influx of scientific and management talent from around the world.
Many of our companies have gone on to address many life threatening and life limiting diseases in Immunology, Oncology and Infection and the Life Science team at OSE would love to see if there are projects that could benefit from translational funding ahead of the commercialising the research. In the Session we plan to talk a little about some of the ways we can work to help support translational efforts and company creation including a variety of funding models and initiatives that we think could be of interest to researchers at the Institute.
Date: 27 November 2023, 12:00 (Monday, 8th week, Michaelmas 2023)
Venue: Kennedy Institute of Rheumatology, Headington OX3 7FY
Venue Details: Bernard Sunley Lecture Theatre
Speakers: Claire Brown (Oxford Science Enterprises), Craig Fox (Oxford Science Enterprises), Sally Dewhurst (Oxford Science Enterprises), Katharina Ramshorn (Oxford Science Enterprises), Sanne de Jongh (Oxford Science Enterprises)
Organising department: Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS)
Organiser: Doris Chan (Kennedy Institute of Rheumatology)
Organiser contact email address: doris.chan@kennedy.ox.ac.uk
Host: Professor Kim Midwood (Kennedy Institute of Rheumatology)
Part of: Kennedy Institute Seminars
Booking required?: Not required
Audience: Members of the University only
Editor: Doris Chan